en
Feedback
PACEMAKER | 2.0 |

PACEMAKER | 2.0 |

Open in Telegram

Fundamental fanlar Klinik fanlar Tez tibbiy yordam ko'rsatish ESC tavsiyalari asosida bilimlarga ega bo'ling. Kanal manzili:👇 https://t.me/PACEMAKER_2 Instagram: cardio_arrythmology https://www.youtube.com/@Pacemaker_academy

Show more
4 799
Subscribers
-624 hours
-197 days
-9030 days
Posts Archive
Assalomu alaykum hayrli tong barchaga. Kunni EKG taxlil bilan boshlaymiz❤️
Assalomu alaykum hayrli tong barchaga. Kunni EKG taxlil bilan boshlaymiz❤️

Javoblar
Anonymous voting

Javoblar
Anonymous voting

Quyidagi EKG uchun mosini belgilang
Quyidagi EKG uchun mosini belgilang

Case 2: 74 yoshli NSTEMI bemor: Atrial fibrillyatsiya (CHA₂DS₂-VASc = 5) PCI + DES bajarildi Guideline bo‘yicha eng to‘g‘ri antitrombotik strategiya qaysi? A. Aspirin + klopidogrel + varfarin 12 oy B. Aspirin + tikagrelor + DOAC 12 oy C. DOAC + klopidogrel (aspirinsiz) D. Faqat DOAC E. Uch komponentni umuman bermaslik

Toʻgʻri javobni belgilang
Anonymous voting

Toʻgʻri javobni belgilang
Anonymous voting

Quyidagilardan EKG uchun mosini belgilang?
Quyidagilardan EKG uchun mosini belgilang?

Case 1: 56 yoshli erkak STEMI bilan kelgan. PCI markazi uzoq bo‘lgani sababli alteplaza berilgan. 90 daqiqadan so‘ng: Og‘riq saqlanmoqda ST elevatsiya <30% kamaygan Gemodinamika nisbatan barqaror Eng to‘g‘ri keyingi qadam qaysi? A. Trombolizisni takrorlash B. 24 soat kutib, PCI C. Zudlik bilan rescue PCI D. Faqat antikoagulyant terapiya E. CABG

💛💛💛 Quizlar Caselar bor tayyormisizlar

Arrhythmia and Palpitations in Women - 2025 Update Scripps Arrhythmias and Cardiomyopathy in Women Symposium 2025 ______________________________________ Free Videos : https://t.me/Ob_gyn_courses/121 https://medustudy.com/product/scripps-arrhythmias-and-cardiomyopathy-in-women-symposium-2025/ Free Videos : https://t.me/Ob_gyn_courses/121

photo content

Chronic Heart Failure 🫀Definition &amp; Classification • Heart failure (HF) = inability of heart to fill or pump enough bloo
+6
Chronic Heart Failure 🫀Definition & Classification • Heart failure (HF) = inability of heart to fill or pump enough blood to meet body needs • Progressive disease with cardiac remodeling • AHA/ACC Stages • A: At risk, no structural disease • B: Structural disease, no symptoms • C: Structural disease + symptoms • D: End-stage HF • NYHA Classes • I: No limitation • II: Symptoms with moderate exertion • III: Symptoms with mild exertion • IV: Symptoms at rest 📊 Epidemiology • ~ 1 million hospitalizations/year • 25% readmission within 30 days • USA: 550,000 new cases/year, >250,000 deaths • Worldwide: 64 million people with HF • 75% hospitalizations occur in patients >65 years • HFpEF now accounts for >50% of cases ⚙️ Types, Etiology & Risk Factors HF Categories • HFrEF: EF ≤40% – systolic dysfunction • HFmEF: EF 41–49% • HFpEF: EF ≥50% – diastolic dysfunction Common Causes • CAD / MI, Hypertension • Cardiomyopathies, valvular disease • Arrhythmias (AF, heart block) • Lung disease, pulmonary HTN, high-output states Risk Factors • CAD, HTN, diabetes, obesity • Smoking, cardiotoxic drugs, older age 🩺 Clinical Features & Diagnosis Symptoms • Dyspnea on exertion, orthopnea, PND • Fatigue, nocturnal cough, edema • RUQ fullness, nausea (right-sided HF) Signs • Raised JVP, rales, S3, hepatomegaly, ascites • Cool extremities, hypotension in severe HF Framingham Criteria: 2 major or 1 major + 2 minor 🔬Investigations • BNP / NT-proBNP • BNP <100 pg/mL → rules out HF • BNP >400 pg/mL → supports HF • Echocardiography: EF, valves, LV/RV function • CXR: cardiomegaly, pulmonary edema • ECG: ischemia, arrhythmia • MRI / Cath / Nuclear imaging in selected cases Guideline-Directed Therapy Core 4 Drugs • ACEi / ARB / ARNI • β-blocker • MRA (spironolactone/eplerenone) • SGLT-2 inhibitors (dapagliflozin / empagliflozin) Others • Loop diuretics for congestion • Hydralazine + nitrates (if ACEi/ARB intolerant) • Ivabradine, vericiguat, digoxin in selected patients • Avoid NSAIDs & non-DHP CCBs in HFrEF 🛠️ Devices, Follow-up & Prognosis Device Therapy • CRT: LVEF ≤35%, QRS ≥150 ms, LBBB • ICD: LVEF ≤35% for sudden death prevention Advanced Options • Mitral repair, LVAD, transplant (NYHA III–IV refractory) Follow-up & Education • Review every 6–12 months • Daily weight monitoring • Low-sodium diet, fluid ~2 L/day Prognosis • 1-year survival ~75% • 5-year survival <50% 🩺 Подпишитесь на наш канал: https://t.me/kardiologi

👉 Emlash kalendari https://t.me/PACEMAKER_2
👉
Emlash kalendari
https://t.me/PACEMAKER_2

Repost from Apikal MED💊
😎 APIKAL MED JAMOASI 📢 Online Tez Tibbiy Yordam kurslariga navbatdagi qabul boshlandi ! 💊 KURSIMIZ ORQALI NIMALARGA EGA BO’LASIZ: 🖥 Batafsil Yuqoridagi Videoda keltirilgan! ➡️Taqdim etgan Sertifikatlarimiz: 💯 SERTIFIKATLAR 📍ustiga bosing 🖥 Ma'lumot uchun: Kursda o’tiladigan Mavzular 📍bosing 🎥 Kursimizni tamomlagan o’quvchilar fikr va mulohazlari: 🔗 https://t.me/Apikal_med_1_feedback 🔴 Qabulga yozilish va batafsil Malumot olish uchun: @Manager_Apikal_Med 🗓 Dars vaqtlari: ➡️Dushanba / Chorshanba / Juma - 20:00 ➡️Seshanba / Payshanba / Shanba - 20:30

Doktorlarga ulashib qo'ying....✊

# EKG tahlili
Kanalga joylangan 15 ga yaqin EKG namunlari tahlili. 🟢 Gipertrofiya 🟢 Blokada 🟢 Bo'lmachalar fibrillyatsiyasi 🟢 STEMI + atrial fibrillation 🟢 Wellens 🟢 Qorinchalar ekstrasistoliyasi https://t.me/PACEMAKER_2

sticker.webp0.17 KB